Literature DB >> 23825190

Effect of prolonged incubation time on results of the QuantiFERON TB gold in-tube assay for diagnosis of latent tuberculosis infection.

Joo-Won Min1, Ha-Youn Lee, Ji Sun Lee, Jinwoo Lee, Jae Ho Chung, Sung Koo Han, Jae-Joon Yim.   

Abstract

Previous reports have shown that the sensitivity of the 6-day lymphocyte stimulation test is much higher than those of commercially available gamma interferon release assays (IGRAs). The aim of this study was to elucidate the effect of prolonged incubation on the results of the QuantiFERON TB Gold in-tube (QFT-GIT) assay. Patients aged >20 years with suspected tuberculosis (TB) were recruited prospectively from 1 May 2009 to 31 December 2010. In addition, healthy volunteers with no history of TB treatment were included as controls. For each participant, three sets of the QFT-GIT assay were performed using 24-, 48-, and 72-h incubation tests, and the results were compared. Thirty-seven patients with suspected pulmonary TB and 33 healthy controls were enrolled in the study. Of the 37 patients with suspected TB, the QFT-GIT assay results were positive for 28 (75.7%) after a 24-h incubation period. After prolonged incubation, the results differed in four (10.8%) of the 37 patients suspected of having TB. Among 27 patients with culture-confirmed TB, the sensitivities of the QFT-GIT assay after the 24-, 48-, and 72-h incubation tests were 85.2%, 81.5%, and 81.5%, respectively. Among the 33 healthy controls, the QFT-GIT assay results were positive in two (6.1%) after a 24-h incubation period. The results changed for two (6.1%) of the 33 healthy controls after prolonged incubation. The specificities of the QFT-GIT assay after 24, 48, and 72 h of incubation were 93.9%, 87.9%, and 90.9%, respectively. Prolonging the incubation time did not increase the sensitivity of the QFT-GIT assay. The manufacturer-recommended incubation time of 16 to 24 h should be respected because prolonged incubation can cause indeterminate or false-positive results.

Entities:  

Mesh:

Year:  2013        PMID: 23825190      PMCID: PMC3889582          DOI: 10.1128/CVI.00290-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  8 in total

1.  Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay.

Authors:  Victor Herrera; Ellen Yeh; Kelly Murphy; Julie Parsonnet; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection.

Authors:  David Doberne; Rajiv L Gaur; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

3.  Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens.

Authors:  Martine G Aabye; Pernille Ravn; Isik S Johansen; Jesper Eugen-Olsen; Morten Ruhwald
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

4.  Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia.

Authors:  K Shanaube; P De Haas; A Schaap; M Moyo; B Kosloff; A Devendra; E Raby; P Godfrey-Faussett; H Ayles
Journal:  Int J Tuberc Lung Dis       Date:  2010-07       Impact factor: 2.373

5.  Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.

Authors:  Young Ae Kang; Hye Won Lee; Ho Il Yoon; BeLong Cho; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

Review 6.  New diagnostics for latent and active tuberculosis: state of the art and future prospects.

Authors:  Madhukar Pai; Richard O'Brien
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

Review 7.  Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Authors:  Madhukar Pai; Alice Zwerling; Dick Menzies
Journal:  Ann Intern Med       Date:  2008-06-30       Impact factor: 25.391

8.  Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.

Authors:  Eliane M S Leyten; Sandra M Arend; Corine Prins; Frank G J Cobelens; Tom H M Ottenhoff; Jaap T van Dissel
Journal:  Clin Vaccine Immunol       Date:  2007-05-16
  8 in total
  1 in total

Review 1.  Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.

Authors:  Saloua Tagmouti; Madeline Slater; Andrea Benedetti; Sandra V Kik; Niaz Banaei; Adithya Cattamanchi; John Metcalfe; David Dowdy; Richard van Zyl Smit; Nandini Dendukuri; Madhukar Pai; Claudia Denkinger
Journal:  Ann Am Thorac Soc       Date:  2014-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.